These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33830989)

  • 1. Leprosy postexposure prophylaxis with single-dose rifampicin: Nepalese dermatologist's dilemma.
    Parajuli N; Poudyal Y
    PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009039. PubMed ID: 33830989
    [No Abstract]   [Full Text] [Related]  

  • 2. Leprosy Post-Exposure Prophylaxis (LPEP) programme: study protocol for evaluating the feasibility and impact on case detection rates of contact tracing and single dose rifampicin.
    Barth-Jaeggi T; Steinmann P; Mieras L; van Brakel W; Richardus JH; Tiwari A; Bratschi M; Cavaliero A; Vander Plaetse B; Mirza F; Aerts A;
    BMJ Open; 2016 Nov; 6(11):e013633. PubMed ID: 27856484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leprosy post-exposure prophylaxis with single-dose rifampicin (LPEP): an international feasibility programme.
    Richardus JH; Tiwari A; Barth-Jaeggi T; Arif MA; Banstola NL; Baskota R; Blaney D; Blok DJ; Bonenberger M; Budiawan T; Cavaliero A; Gani Z; Greter H; Ignotti E; Kamara DV; Kasang C; Manglani PR; Mieras L; Njako BF; Pakasi T; Pandey BD; Saunderson P; Singh R; Smith WCS; Stäheli R; Suriyarachchi ND; Tin Maung A; Shwe T; van Berkel J; van Brakel WH; Vander Plaetse B; Virmond M; Wijesinghe MSD; Aerts A; Steinmann P
    Lancet Glob Health; 2021 Jan; 9(1):e81-e90. PubMed ID: 33129378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introducing leprosy post-exposure prophylaxis into the health systems of India, Nepal and Indonesia: a case study.
    Tiwari A; Mieras L; Dhakal K; Arif M; Dandel S; Richardus JH;
    BMC Health Serv Res; 2017 Sep; 17(1):684. PubMed ID: 28962564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negligible risk of inducing resistance in Mycobacterium tuberculosis with single-dose rifampicin as post-exposure prophylaxis for leprosy.
    Mieras L; Anthony R; van Brakel W; Bratschi MW; van den Broek J; Cambau E; Cavaliero A; Kasang C; Perera G; Reichman L; Richardus JH; Saunderson P; Steinmann P; Yew WW
    Infect Dis Poverty; 2016 Jun; 5(1):46. PubMed ID: 27268059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long-term impact of the Leprosy Post-Exposure Prophylaxis (LPEP) program on leprosy incidence: A modelling study.
    Blok DJ; Steinmann P; Tiwari A; Barth-Jaeggi T; Arif MA; Banstola NL; Baskota R; Blaney D; Bonenberger M; Budiawan T; Cavaliero A; Gani Z; Greter H; Ignotti E; Kamara DV; Kasang C; Manglani PR; Mieras L; Njako BF; Pakasi T; Saha UR; Saunderson P; Smith WCS; Stäheli R; Suriyarachchi ND; Tin Maung A; Shwe T; van Berkel J; van Brakel WH; Vander Plaetse B; Virmond M; Wijesinghe MSD; Aerts A; Richardus JH
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009279. PubMed ID: 33788863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Informal consultation on rifampicin resistance in leprosy.
    Lepr Rev; 2007 Sep; 78(3):295-305. PubMed ID: 18035782
    [No Abstract]   [Full Text] [Related]  

  • 8. Leprosy post-exposure prophylaxis in the Indian health system: A cost-effectiveness analysis.
    Tiwari A; Blok DJ; Arif M; Richardus JH
    PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008521. PubMed ID: 32750059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population screening and chemoprophylaxis for household contacts of leprosy patients in the Republic of the Marshall Islands.
    Tin K
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4 Suppl):S26-9. PubMed ID: 10700934
    [No Abstract]   [Full Text] [Related]  

  • 10. Protocol, rationale and design of PEOPLE (Post ExpOsure Prophylaxis for LEprosy in the Comoros and Madagascar): a cluster randomized trial on effectiveness of different modalities of implementation of post-exposure prophylaxis of leprosy contacts.
    Ortuno-Gutierrez N; Younoussa A; Randrianantoandro A; Braet S; Cauchoix B; Ramboarina S; Baco A; Mzembaba A; Salim Z; Amidy M; Grillone S; Richardus JH; de Jong BC; Hasker E
    BMC Infect Dis; 2019 Dec; 19(1):1033. PubMed ID: 31805862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polytherapy in multibacillary leprosy patients in Nepal.
    Samuel NM; Samual S; Fairbairn T; Adiga RB
    Singapore Med J; 1985 Apr; 26(2):203-6. PubMed ID: 4035403
    [No Abstract]   [Full Text] [Related]  

  • 12. Rifampicin: the investigation of a bactericidal antileprosy drug.
    Rees RJ
    Lepr Rev; 1975 Jun; 46(2 Suppl):121-4. PubMed ID: 1100951
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of leprosy with rifampicin and isoprodian (L73A).
    Terencio de las Aguas J
    Lepr Rev; 1975 Jun; 46(2 Suppl):165-8. PubMed ID: 1100956
    [No Abstract]   [Full Text] [Related]  

  • 14. Rifampicin and isoprodian in combination in the treatment of leprosy.
    Depasquale G
    Lepr Rev; 1975 Jun; 46(2 Suppl):179-80. PubMed ID: 1100958
    [No Abstract]   [Full Text] [Related]  

  • 15. [How should leprosy be treated?].
    Mahé A
    Ann Dermatol Venereol; 1998 Dec; 125(12):881-3. PubMed ID: 9922859
    [No Abstract]   [Full Text] [Related]  

  • 16. An unusual reaction to rifampicin in a once monthly dose.
    Sule RR
    Lepr Rev; 1996 Sep; 67(3):227-8. PubMed ID: 8885617
    [No Abstract]   [Full Text] [Related]  

  • 17. Rifampicin/minocycline and ofloxacin (ROM) for single lesions--what is the evidence?
    Lockwood DN
    Lepr Rev; 1997 Dec; 68(4):299-300. PubMed ID: 9503865
    [No Abstract]   [Full Text] [Related]  

  • 18. The Role of Rifampin in Leprosy : Leprosy Through a New Lens.
    Allen HB; Moschella SL
    JAMA Dermatol; 2017 Mar; 153(3):261-262. PubMed ID: 28196219
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical and bacteriological effects of rifampicin in combination with L73A in leprosy: observation for six months.
    Innami S; Leguizamón OR; Alvarenga AE
    Lepr Rev; 1975 Jun; 46(2 Suppl):169-72. PubMed ID: 1100957
    [No Abstract]   [Full Text] [Related]  

  • 20. Preliminary experience with combined therapy using rifampicin and isoprodian (L73A).
    Freerksen E
    Lepr Rev; 1975 Jun; 46(2 Suppl):161-3. PubMed ID: 1165695
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.